Metaproteogenomic analysis of saliva samples from Parkinson's disease patients with cognitive impairment

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: npj Biofilms and Microbiomes, 9, 1, S. 1-10

Event
Veröffentlichung
(where)
Berlin
(who)
Bundesanstalt für Materialforschung und -prüfung (BAM)
(when)
2025
Creator
Arıkan, Muzaffer
Demir, Tuğçe Kahraman
Yıldız, Zeynep
Nalbantoğlu, Özkan Ufuk
Korkmaz, Nur Damla
Yılmaz, Nesrin H.
Şen, Aysu
Özcan, Mutlu
Muth, Thilo
Hanoğlu, Lütfü
Yıldırım, Süleyman

DOI
10.1038/s41522-023-00452-x
URN
urn:nbn:de:kobv:b43-624228
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Arıkan, Muzaffer
  • Demir, Tuğçe Kahraman
  • Yıldız, Zeynep
  • Nalbantoğlu, Özkan Ufuk
  • Korkmaz, Nur Damla
  • Yılmaz, Nesrin H.
  • Şen, Aysu
  • Özcan, Mutlu
  • Muth, Thilo
  • Hanoğlu, Lütfü
  • Yıldırım, Süleyman
  • Bundesanstalt für Materialforschung und -prüfung (BAM)

Time of origin

  • 2025

Other Objects (12)

Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment

Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment

Advanced brain aging in Parkinson’s disease with cognitive impairment

Advanced brain aging in Parkinson’s disease with cognitive impairment

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Cognitive reorganization in patients with Parkinson’s Disease and Mild Cognitive Impairment: a neuropsychological network approach

Cognitive reorganization in patients with Parkinson’s Disease and Mild Cognitive Impairment: a neuropsychological network approach

Interactions between functional networks in Parkinson's disease mild cognitive impairment

Interactions between functional networks in Parkinson's disease mild cognitive impairment

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Related objects